Log Out

Weekly Drug Pipeline Calendar (Sept 26- Sept 30)

BioPharm Insight US wrote a column · Sep 26, 2022 09:52

Weekly Drug Pipeline Calendar (Sept 26- Sept 30)

Announcement Document

$X4 Pharmaceuticals (XFOR.US)$: X4 Pharmaceuticals to Host Investor Webinar Highlighting New Mavorixafor Phase 1b Data in Chronic Neutropenia

$Aslan Pharmaceuticals (ASLN.US)$: ASLAN Pharmaceuticals Announces Acceptance of Two Late-Breaking Abstracts for E-Poster Presentation

$Amylyx Pharmaceuticals (AMLX.US)$: Amylyx Pharmaceuticals Announces FDA Advisory Committee Supports Approval of AMX0035 for the Treatment of ALS

$IVERIC bio (ISEE.US)$: Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy

$Biomarin Pharmaceutical (BMRN.US)$: BioMarin's Gene Therapy for Adults with Severe Hemophilia A, ROCTAVIAN™ (valoctocogene roxaparvovec), Assessed to Provide Substantial Cost Savings Per Patient in a Preliminary Independent Report

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

+0

15

5

Translate

Report

45K Views

Comment

Sign in to post a comment

SpyderCall : Epic! keep the FDA news coming in. This stuff can be valuable

Report
Reply

Cancel Reply
VaderStocks SpyderCall : Only if it moves PFE or MRO

Report
Reply

Cancel Reply
Luis Chaparro : share more

Report
Reply

Cancel Reply
Dons hobby : Very nice, I didn't even know this type of information was available.

Report
Reply

Cancel Reply
Island buoy : Keep this up. This can enhance our trading

Report
Reply

Cancel Reply

BioPharm Insight US

We are the content provider of Moomoo Courses.

913Followers

8Following

1481Visitors

Follow